- Report
- January 2026
- 181 Pages
Global
From €3436EUR$3,939USD£2,992GBP
- Report
- January 2026
- 188 Pages
Global
From €3436EUR$3,939USD£2,992GBP
- Report
- September 2025
- 250 Pages
Global
From €3917EUR$4,490USD£3,411GBP
- Report
- September 2025
- 250 Pages
Global
From €3917EUR$4,490USD£3,411GBP
- Report
- September 2025
- 250 Pages
Global
From €3917EUR$4,490USD£3,411GBP
- Report
- February 2026
- 278 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- October 2025
- 250 Pages
Global
From €3917EUR$4,490USD£3,411GBP
- Report
- November 2025
- 185 Pages
Global
From €3925EUR$4,500USD£3,419GBP
- Report
- August 2025
- 136 Pages
Global
From €3488EUR$3,999USD£3,038GBP
- Report
- February 2025
- 135 Pages
Global
From €15697EUR$17,995USD£13,671GBP
- Report
- October 2025
- 160 Pages
Global
From €3446EUR$3,950USD£3,001GBP
- Report
- October 2025
- 100 Pages
United States
From €5190EUR$5,950USD£4,520GBP
- Report
- January 2024
- 150 Pages
Global
From €5190EUR$5,950USD£4,520GBP
- Report
- August 2022
- 120 Pages
Global
From €3925EUR$4,500USD£3,419GBP
- Report
- April 2024
- 115 Pages
Global
From €3925EUR$4,500USD£3,419GBP
- Report
- March 2024
- 200 Pages
Global
From €3620EUR$4,150USD£3,153GBP
- Report
- December 2024
- 30 Pages
Global
From €2399EUR$2,750USD£2,089GBP
- Report
- December 2024
- 30 Pages
Global
From €2399EUR$2,750USD£2,089GBP
- Report
- December 2024
- 30 Pages
Global
From €2399EUR$2,750USD£2,089GBP
- Report
- July 2024
- 150 Pages
Global
From €3271EUR$3,750USD£2,849GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more